Elevance Health Inc. (ELV) — Financial statements
Income statement, balance sheet, and cash flow for Elevance Health Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 199,125↑12.6% | 176,810↑3.2% | 171,340↑9.4% | 156,595↑13.0% | 138,639 | |
| Cost of Revenue | 148,223↑16.2% | 127,567↑2.6% | 124,330↑6.6% | 116,642↑13.6% | 102,645 | |
| Gross Profit | 50,902↑3.4% | 49,243↑4.8% | 47,010↑17.7% | 39,953↑11.0% | 35,994 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Expenses | 42,790↑6.0% | 40,355↑5.5% | 38,265↑21.5% | 31,502↑16.5% | 27,048 | |
| Operating Expenses | 42,790↑6.0% | 40,355↑5.5% | 38,265↑21.5% | 31,502↑16.5% | 27,048 | |
| Total Costs & Expenses | 191,013↑13.8% | 167,922↑3.3% | 162,595↑9.8% | 148,144↑14.2% | 129,693 | |
| Operating Results | ||||||
| Operating Income | 8,112↓8.7% | 8,888↑1.6% | 8,745↑3.5% | 8,451↓5.5% | 8,946 | |
| Depreciation & Amortization | 1,546↑11.0% | 1,393↓20.2% | 1,745↑4.2% | 1,675↑28.6% | 1,302 | |
| EBITDA | 9,658↓7.9% | 10,482↓0.1% | 10,490↑3.6% | 10,126↑1.0% | 10,025 | |
| EBIT | 8,112↓10.7% | 9,089↑3.9% | 8,745↑3.5% | 8,451↓3.1% | 8,723 | |
| Interest & Other Income | ||||||
| Net Interest Income | -1,402↓18.3% | -1,185↓15.0% | -1,030↓21.0% | -851↓6.6% | -798 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 1,402↑18.3% | 1,185↑15.0% | 1,030↑21.0% | 851↑6.6% | 798 | |
| Non-Operating Income | 0.00↑100.0% | -201 | 0.00 | 0.00↓100.0% | 223 | |
| Other Income / Expenses | -1,402↓42.5% | -984↑4.5% | -1,030↓21.0% | -851↑16.7% | -1,021 | |
| Income Before Tax | 6,710↓15.1% | 7,904↑2.4% | 7,715↑1.5% | 7,600↓4.1% | 7,925 | |
| Income Tax Expense | 1,049↓45.7% | 1,933↑12.1% | 1,724↑0.7% | 1,712↓6.4% | 1,830 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 5,661↓5.2% | 5,971↓0.3% | 5,991↑1.7% | 5,888↓3.4% | 6,095 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 5,662↓5.3% | 5,980↓0.1% | 5,987↑1.6% | 5,894↓3.4% | 6,104 | |
| Bottom-Line Net Income | 5,662↓5.3% | 5,980↓0.1% | 5,987↑1.6% | 5,894↓3.4% | 6,104 | |
| EPS (Basic) | 25.18↓2.4% | 25.81↑1.7% | 25.38↑3.3% | 24.56↓2.7% | 25.25 | |
| EPS (Diluted) | 25.12↓2.2% | 25.68↑1.8% | 25.22↑3.9% | 24.28↓1.8% | 24.73 | |
| Weighted Average Shares | 222↓4.8% | 233↓0.1% | 233↓2.9% | 240↓1.6% | 244 | |
| Weighted Average Diluted Shares | 222↓4.8% | 233↓1.9% | 237↓2.2% | 243↓1.6% | 247 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.